IVD Reagents Market to be Worth $79.76 Billion by 2031 - Exclusive Report by Meticulous Research®
07.08.2025 - 18:06:07Among the types, in 2024, the antibodies segment is expected to account for the largest share of 22.1% of the IVD reagents market. The large share of this segment is mainly attributed to the widespread application of antibodies in medicine for research, diagnosis, drug & IVD development, & disease treatment; increasing proteomics & genomics-based research; funding for R&D; and rising need for disease-specific biomarkers.
Among the technologies, in 2024, the immunoassay/immunochemistry segment is expected to account for the largest share of 30.8% of the IVD reagents market. The large share of this segment is mainly attributed to the rising demand for immunoassay-based tests and the significant benefits of these technologies, such as rapid, convenient, and accurate results for the detection and quantitation of targets; continuous development of new biomarkers; cost-benefit; and growing adoption of automated platforms for ELISA.
Among the uses, in 2024, the clinical use segment is expected to account for the largest share of the IVD reagents market. The large market share of this segment can be attributed to the growing need for the early detection of various epidemic and pandemic infections and Initiatives by manufacturers for the development of advanced IVD reagents for clinical applications.
Among the end users, in 2024, the IVD manufacturers segment is expected to account for the largest share of 35% of the IVD reagents market. The large market share of this segment can be attributed to the increasing demand for innovative products and the growing incidence of infectious diseases.
Based on geography, the global IVD reagents market is segmented into North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland. Netherlands, Rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, Singapore, Rest of Asia-Pacific), Latin America, and the Middle East & Africa. In 2024, North America is expected to account for the largest share of 37.7% of the global IVD reagents market. North America's major market share can be attributed to the rising funds and investments for research reagents, increasing adoption of automated instruments, growing automation in clinical & hospital laboratories, and increasing prevalence of infectious diseases.
However, Asia-Pacific is slated to register the highest CAGR during the forecast period. This is attributed to factors such as rapid urbanization, increasing investments by healthcare providers towards infrastructure improvement, the presence of key IVD reagent companies in countries like China, India, Singapore, and South Korea, and government investments in research and development activities. Furthermore, the need to manage the growing burden of infectious diseases, growing accessibility to healthcare services & advanced products, growing income levels of the middle-class population, and increasing number of hospitals and clinics contribute to the growth of this market.
Browse In-depth Report Now- https://www.meticulousresearch.com/product/ivd-reagents-market-5110
Scope of the Report:
IVD Reagents Market Size & Trend Analysis—by Type
AntibodiesAntibodies Market, By TypeMonoclonal AntibodiesPolyclonal AntibodiesAntibodies Market, By TargetCluster of Differentiation (CD)T-cell Receptor (TCR)Epidermal Growth Factor Receptor (EGFR)Other TargetsPurified Proteins and PeptidesOligonucleotidesNucleic Acid ProbesOther ReagentsNotes: 1. Other targets include Nucleic BCMA, DLL/Notch, EpCAM, HER2, PDGFR?, Claudin 18.2, SLAMF7, and DKK1. B-cell maturation antigen (BCMA).
2. Other reagents include blocking agents, detergents, surfactants, wetting agents, buffers, stabilizers, purified water, dyes, standards and controls, enzymes, cell culture reagents, and anti-coagulants.
IVD Reagents Market Size & Trend Analysis—by Technology
Immunoassay/ImmunochemistryEnzyme-linked Immunosorbent Assays (ELISA) and Enzyme-linked Immunospot Assays (ELISpot)Lateral Flow Assays (LFA)/Rapid TestsWestern Blotting (WB)Immunofluorescence (IF)Functional AssaysImmunoprecipitation (IP)Other Immunoassay TechnologiesBiochemistry/Clinical ChemistryMolecular DiagnosticsPolymerase Chain Reaction (PCR)HybridizationIsothermal Nucleic Acid Amplification TechnologyDNA Sequencing & Next-generation SequencingMicroarrayOther Molecular Diagnostic TechnologiesMicrobiologyHematologyCoagulation/HemostasisUrinalysisOther IVD TechnologiesNote: 1. Other technologies include virus neutralization tests, agar gel immunodiffusion, and radioimmunoassay.
2. Other molecular diagnostic technologies include electrophoresis, ligase chain reaction (LCR), northern blot, and southern blot.
3. Other IVD technologies include anatomical pathology, histochemistry, and whole blood glucose monitoring.
IVD Reagents Market Size & Trend Analysis—by Use
Clinical UseResearch Use Only (RUO)Analyte-specific Reagents (ASR)IVD Reagents Market Size & Trend Analysis—by End User
Reference LaboratoriesIVD ManufacturersAcademic Institutes and Research LaboratoriesHospital LaboratoriesIVD Reagents Market Size & Trend Analysis—by Geography
North AmericaU.S.CanadaEuropeGermanyFranceItalyU.K.SpainSwitzerlandNetherlandsRest of EuropeAsia-PacificChinaJapanIndiaSouth KoreaAustraliaSingaporeRest of Asia-PacificLatin AmericaBrazilMexicoRest of Latin AmericaMiddle East & AfricaUnlock Opportunities: Buy Now- https://www.meticulousresearch.com/Checkout/21348226
Related Reports:
In-vitro Diagnostics Market by Offering (Kits, Software), Technology (Immunoassay, Molecular Diagnostics [PCR, NGS, Microarray], Rapid Tests, Biochemistry), Application (Infectious Diseases, Oncology), Diagnostic Approach (Lab, POC) - Global Forecast to 2030
Point-of-care Diagnostics Market by Application (Influenza, Pneumonia, HAI, Salmonellosis, Hepatitis, HIV, COVID, Pregnancy, Glucose Monitoring, Hematology, Tumor Marker, Urinalysis), Platform (LFA, Molecular), Sample, End User - Global Forecast to 2030
Molecular Diagnostics Market by Product (Reagent & Kits, Systems, Software), Test Type (Lab, PoC), Technology (PCR, ISH, INAAT, Sequencing, Microarray), Application (Infectious Diseases, Oncology), End User (Hospital, Diagnostic Lab) - Global Forecast to 2030
IVD Contract Manufacturing Services Market by Type (Assay Development, Manufacturing), Category (Reagents, Systems), Technology (Immunoassay, Molecular Diagnostics, Clinical Chemistry, Hematology, Microbiology, Urinalysis) - Global Forecast to 2028
IVD Quality Controls Market by Product Type (Quality Controls, Data Management Software, and External Quality Assurance Services), by Application (Clinical Chemistry, Hematology, Immunoassay, Molecular Diagnostics, Microbiology, Coagulation/Hemostasis, and Others), by End User (Hospitals, Clinical/ Reference Laboratories, Research and Academic Institutes, and others), by Manufacturer Type (IVD Instrument Manufacturers and Third Party Quality Control Manufacturers) - Global Forecast to 2022
Africa IVD Market by Product & Solution, Technology (Immunoassay, Point of Care, Molecular Diagnostics, Coagulation), Application (Infectious Diseases, Diabetes, Oncology), Diagnostic Approach (Lab, OTC, PoC), End User - Forecast to 2031
Latin America In Vitro Diagnostics Market by Product & Solution, Technology (Immunoassay, Point of Care, Molecular Diagnostics), Application (Infectious Diseases, Diabetes, Oncology), Diagnostic Approach (Lab, OTC, PoC), End User - Forecast to 2030
About Meticulous Research®
Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.
Contact:
Mr. Khushal Bombe
Meticulous Market Research Inc.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
USA: +1-646-781-8004
Europe: +44-203-868-8738
APAC: +91 744-7780008
Email- sales@meticulousresearch.com
Visit Our Website: https://www.meticulousresearch.com/
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Content Source: https://www.meticulousresearch.com/pressrelease/58/ivd-reagents-market-2031
Logo: https://mma.prnewswire.com/media/1757980/Meticulous_Research_Logo_1.jpg
View original content:https://www.prnewswire.co.uk/news-releases/ivd-reagents-market-to-be-worth-79-76-billion-by-2031---exclusive-report-by-meticulous-research-302189644.html
